MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 93 filers reported holding MEI PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | -66.7% | 14,060 | -4.3% | 0.00% | -90.0% |
| Q1 2020 | $24,000 | -81.1% | 14,690 | -71.3% | 0.01% | -73.7% |
| Q4 2019 | $127,000 | +47.7% | 51,157 | 0.0% | 0.04% | +18.8% |
| Q3 2019 | $86,000 | -11.3% | 51,157 | +31.9% | 0.03% | -11.1% |
| Q2 2019 | $97,000 | +67.2% | 38,797 | +105.4% | 0.04% | +9.1% |
| Q1 2019 | $58,000 | -7.9% | 18,890 | +28.2% | 0.03% | +135.7% |
| Q3 2018 | $63,000 | -69.6% | 14,731 | -85.3% | 0.01% | -65.0% |
| Q1 2018 | $207,000 | -57.8% | 100,140 | -57.2% | 0.04% | -65.5% |
| Q4 2017 | $491,000 | -16.2% | 233,894 | +6.9% | 0.12% | -13.4% |
| Q3 2017 | $586,000 | – | 218,807 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 4,610,423 | $1,782,000 | 0.21% |
| DAFNA Capital Management LLC | 1,767,146 | $683,000 | 0.18% |
| NEA Management Company, LLC | 8,533,072 | $3,299,000 | 0.16% |
| Boxer Capital, LLC | 2,913,091 | $1,126,000 | 0.06% |
| BVF INC/IL | 3,532,057 | $1,365,000 | 0.06% |
| Investmark Advisory Group LLC | 136,000 | $52,000 | 0.05% |
| CARLSON CAPITAL L P | 1,150,000 | $445,000 | 0.03% |
| Artal Group S.A. | 1,000,000 | $387,000 | 0.02% |
| Annandale Capital, LLC | 100,000 | $39,000 | 0.01% |
| Sigma Planning Corp | 641,050 | $248,000 | 0.01% |